PAMORELIN Trademark
Trademark Overview
On Tuesday, August 15, 2017, a trademark application was filed for PAMORELIN with the United States Patent and Trademark Office. The USPTO has given the PAMORELIN trademark a serial number of 87568745. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 23, 2025. This trademark is owned by Debiopharm International SA. The PAMORELIN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertilization, ovarian cancer, fibroma and polycystic ovarian cancer
General Information
Serial Number | 87568745 |
Word Mark | PAMORELIN |
Filing Date | Tuesday, August 15, 2017 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, May 23, 2025 |
Registration Number | 5604338 |
Registration Date | Tuesday, November 13, 2018 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 28, 2018 |
Trademark Statements
Goods and Services | Pharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertilization, ovarian cancer, fibroma and polycystic ovarian cancer |
Translation of Words in Mark | The wording "PAMORELIN" has no meaning in a foreign language. |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, May 23, 2025 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Debiopharm International SA |
Party Type | 30 - Original Registrant |
Legal Entity Type | 33 - NOT AVAILABLE |
Address | Lausanne CH-1002 CH |
Party Name | Debiopharm International SA |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 33 - NOT AVAILABLE |
Address | Lausanne CH-1002 CH |
Party Name | Debiopharm International SA |
Party Type | 10 - Original Applicant |
Legal Entity Type | 33 - NOT AVAILABLE |
Address | Lausanne CH-1002 CH |
Trademark Events
Event Date | Event Description |
Friday, November 17, 2017 | ASSIGNED TO EXAMINER |
Friday, August 18, 2017 | NEW APPLICATION ENTERED |
Monday, August 21, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, July 24, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, August 8, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, August 28, 2018 | PUBLISHED FOR OPPOSITION |
Tuesday, August 28, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 13, 2018 | REGISTERED-PRINCIPAL REGISTER |
Monday, November 13, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Friday, May 23, 2025 | CANCELLED SEC. 8 (6-YR) |
Wednesday, May 30, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, November 20, 2017 | NON-FINAL ACTION WRITTEN |
Monday, November 20, 2017 | NON-FINAL ACTION E-MAILED |
Monday, November 20, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, May 21, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, May 29, 2018 | ASSIGNED TO LIE |
Wednesday, May 30, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |